MEDIAN TECHNOLOGIES (ALMDT.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:ALMDT - FR0011049824 - Common Stock
ALMDT.PA Key Statistics, Chart & Performance
The current stock price of ALMDT.PA is 4.755 EUR. In the past month the price increased by 8.93%. In the past year, price increased by 20.08%.
ALMDT.PA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ALMDT.PA. When comparing the yearly performance of all stocks, ALMDT.PA is one of the better performing stocks in the market, outperforming 91.63% of all stocks.
ALMDT.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALMDT.PA. ALMDT.PA may be in some trouble as it scores bad on both profitability and health.
ALMDT.PA Financial Highlights
Over the last trailing twelve months ALMDT.PA reported a non-GAAP Earnings per Share(EPS) of -1.16. The EPS increased by 9.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -113.84% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALMDT.PA Forecast & Estimates
11 analysts have analysed ALMDT.PA and the average price target is 8.81 EUR. This implies a price increase of 85.19% is expected in the next year compared to the current price of 4.755.
For the next year, analysts expect an EPS growth of 33.59% and a revenue growth 3.31% for ALMDT.PA
ALMDT.PA Ownership
About ALMDT.PA
Company Profile
MEDIAN Technologies SA engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology. The company is headquartered in Valbonne, Paca and currently employs 211 full-time employees. The company went IPO on 2011-05-20. The firm develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The firm operates one subsidiary, Median Technologies Inc, based in the United States.
Company Info
MEDIAN TECHNOLOGIES
Les Deux Arcs - Batiment B 1800, Route des Cretes
Valbonne PACA FR
Employees: 250
Phone: 33493333777
MEDIAN TECHNOLOGIES / ALMDT.PA FAQ
What does MEDIAN TECHNOLOGIES do?
MEDIAN Technologies SA engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology. The company is headquartered in Valbonne, Paca and currently employs 211 full-time employees. The company went IPO on 2011-05-20. The firm develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The firm operates one subsidiary, Median Technologies Inc, based in the United States.
What is the current price of ALMDT stock?
The current stock price of ALMDT.PA is 4.755 EUR. The price increased by 2.04% in the last trading session.
Does ALMDT stock pay dividends?
ALMDT.PA does not pay a dividend.
What is the ChartMill rating of MEDIAN TECHNOLOGIES stock?
ALMDT.PA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the Price/Earnings (PE) ratio of MEDIAN TECHNOLOGIES (ALMDT.PA)?
MEDIAN TECHNOLOGIES (ALMDT.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.16).
What is the employee count for ALMDT stock?
MEDIAN TECHNOLOGIES (ALMDT.PA) currently has 250 employees.
What is the market capitalization of ALMDT stock?
MEDIAN TECHNOLOGIES (ALMDT.PA) has a market capitalization of 174.60M EUR. This makes ALMDT.PA a Micro Cap stock.